Lane NE - Search Results

1

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.

Cosman F, Crittenden DB, Ferrari S, Khan A, Lane NE, Lippuner K, Matsumoto T, Milmont CE, Libanati C, Grauer A. Cosman F, et al. Among authors: lane ne. J Bone Miner Res. 2018 Jul;33(7):1219-1226. doi: 10.1002/jbmr.3427. Epub 2018 May 17. J Bone Miner Res. 2018. PMID: 29573473 Free article. Clinical Trial.

2

Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group.

Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane NE, Hochberg MC, Stone K, Nevitt MC. Bauer DC, et al. Among authors: lane ne. J Bone Miner Res. 1996 Jan;11(1):29-35. doi: 10.1002/jbmr.5650110106. J Bone Miner Res. 1996. PMID: 8770694 Clinical Trial.

3

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A. Adachi JD, et al. Among authors: lane ne. Arthritis Rheum. 2001 Jan;44(1):202-11. doi: 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W. Arthritis Rheum. 2001. PMID: 11212161 Free article. Clinical Trial.

4

Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.

Srivastava AK, Libanati C, Lane N, Baylink DJ. Srivastava AK, et al. J Bone Miner Metab. 2002;20(2):66-72. doi: 10.1007/s007740200009. J Bone Miner Metab. 2002. PMID: 11862527

5

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.

Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF. Lane NE, et al. J Bone Miner Res. 2006 Mar;21(3):466-76. doi: 10.1359/JBMR.051103. Epub 2005 Nov 14. J Bone Miner Res. 2006. PMID: 16491295 Free PMC article.

6

Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.

Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE. Cheng Z, et al. Among authors: lane ne. J Bone Miner Res. 2009 Feb;24(2):209-20. doi: 10.1359/jbmr.81005. J Bone Miner Res. 2009. PMID: 18847326 Free PMC article.

7

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE. Yao W, et al. Among authors: lane ne. J Bone Miner Res. 2010 Feb;25(2):190-9. doi: 10.1359/jbmr.090719. J Bone Miner Res. 2010. PMID: 19594295 Free PMC article.

8

Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women.

Cosman F, Lane NE, Bolognese MA, Zanchetta JR, Garcia-Hernandez PA, Sees K, Matriano JA, Gaumer K, Daddona PE. Cosman F, et al. Among authors: lane ne. J Clin Endocrinol Metab. 2010 Jan;95(1):151-8. doi: 10.1210/jc.2009-0358. Epub 2009 Oct 26. J Clin Endocrinol Metab. 2010. PMID: 19858319 Free PMC article. Clinical Trial.

9

Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.

Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, Heeren D, Burghardt AJ, Nicolella DP, Kimiecik MG, Lane NE. Shahnazari M, et al. Among authors: lane ne. Bone. 2010 May;46(5):1267-74. doi: 10.1016/j.bone.2009.11.019. Epub 2009 Nov 26. Bone. 2010. PMID: 19931661 Free PMC article.

10

Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.

Shahnazari M, Yao W, Wang B, Panganiban B, Ritchie RO, Hagar Y, Lane NE. Shahnazari M, et al. Among authors: lane ne. J Bone Miner Res. 2011 Mar;26(3):569-81. doi: 10.1002/jbmr.249. J Bone Miner Res. 2011. PMID: 20839286 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters